Collagen Solutions plc is a holding company. The Company is engaged in the business of supply, development and manufacture of medical grade collagen components and biomaterials. The Company's products and services are utilized in the research, diagnostics, medical devices and regenerative medicine markets. The Company's main products include Collagen and tissue biomaterials. The Company's product range includes raw tissue supply, including pericardium, which is used in heart valves and dural patches, various strengths of soluble and acid soluble collagen, acid swollen gels, freeze-dried powders, collagen sheets and fibrous collagen. The Company also manufactures Excellagen, a collagen gel used in wound care and cell therapy fields. Its services include product development and contract manufacturing. It offers a range of bovine spongiform encephalopathy (BSE)-free bovine biomaterials to meet customer specifications, including bone, cartilage and tendon, and veins and blood vessels.
Industry, Sector and Symbol:
Capitalization:- Market Cap: £15.81 million
- Outstanding Shares: 324,299,000
Average Prices:- 50 Day Moving Avg: GBX 5.02
- 200 Day Moving Avg: GBX 5.18
- 52 Week Range: GBX 4.25 - GBX 8.90
P/E:- Trailing P/E Ratio: N/A
- P/E Growth: 0.000
Sales & Book Value:- Annual Revenue: £3.95 million
- Price / Sales: 4.00
- Book Value: GBX 0.06 per share
- Price / Book: 0.79
Profitability:- EBIDTA: ($1,400,000.00)
- Net Margins: -34.00%
- Return on Equity: -7.87%
- Return on Assets: -6.47%
Misc:- Average Volume: 194,167 shs.
Frequently Asked Questions for Collagen Solutions PLC (LON:COS)
What is Collagen Solutions PLC's stock symbol?
Collagen Solutions PLC trades on the London Stock Exchange (LON) under the ticker symbol "COS."
Where is Collagen Solutions PLC's stock going? Where will Collagen Solutions PLC's stock price be in 2017?
3 brokers have issued 12-month target prices for Collagen Solutions PLC's shares. Their predictions range from GBX 10 to GBX 10. On average, they expect Collagen Solutions PLC's stock price to reach GBX 10 in the next twelve months. View Analyst Ratings for Collagen Solutions PLC.
Who are some of Collagen Solutions PLC's key competitors?
Some companies that are related to Collagen Solutions PLC include Scancell Holdings Plc (SCLP), Ampio Pharmaceuticals (AMPE), CorMedix (CRMD), Oncobiologics (ONS), Cambridge Cognition Holdings PLC (COG), Capricor Therapeutics (CAPR), Omega Diagnostics Group Plc (ODX), LiDCO Group plc (LID), Surgical Innovations Group Plc (SUN), Biopharmx Corp (BPMX), Biopharmx Corp (BPMX), Biopharmx Corp (BPMX), Venture Life Group PLC (VLG), Scientific Digital Imaging plc (SDI), AdCare Health Systems (ADK), Oxford Pharmascience Group Plc (OXP), Evgen Pharma PLC (EVG) and Advanced Oncotherapy PLC (AVO).
Who are Collagen Solutions PLC's key executives?
Collagen Solutions PLC's management team includes the folowing people:
- Jamal Rushdy, Chief Executive Officer
- Gillian Nancy Black, Chief Financial Officer, Company Secretary, Director
- Geoff Bennett, Chief Business Officer , Director
- David Eric Evans, Non-Executive Chairman of the board
- Malcolm John Gillies, Non-Executive Independent Director
How do I buy Collagen Solutions PLC stock?
Shares of Collagen Solutions PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Collagen Solutions PLC's stock price today?
One share of Collagen Solutions PLC stock can currently be purchased for approximately GBX 4.88.
MarketBeat Community Rating for Collagen Solutions PLC (LON COS)MarketBeat's community ratings are surveys of what our community members think about Collagen Solutions PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Collagen Solutions PLC (LON:COS) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Hold Rating, 2 Buy Ratings |
| Consensus Rating: | Buy (Score: 2.67) |
| Consensus Price Target: | GBX 10 |
Analysts' Ratings History for Collagen Solutions PLC (LON:COS)
Show:
| Date | Firm | Action | Rating | Price Target | Details |
|---|
| 7/11/2017 | Cenkos Securities Ltd | Reiterated Rating | Buy | |  |
| 12/20/2016 | Beaufort Securities | Downgrade | Speculative Buy | | |
| 10/13/2016 | Panmure Gordon | Reiterated Rating | Buy | | |
(Data available from 8/18/2015 forward)
Earnings History for Collagen Solutions PLC (LON:COS)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Collagen Solutions PLC (LON:COS)Current Year EPS Consensus Estimate: $-0.750 EPS
Dividend History for Collagen Solutions PLC (LON:COS)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Collagen Solutions PLC (LON:COS)Insider Trades by Quarter for Collagen Solutions PLC (LON:COS)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 7/25/2017 | David Evans | Insider | Buy | 900,000 | GBX 5 | £45,000 | |
| 3/23/2017 | David Evans | Insider | Buy | 434,950 | GBX 1 | £4,349.50 | |
| 7/12/2016 | Evans,David | Insider | Buy | 185,000 | GBX 8 | £14,800 | |
| 7/8/2016 | Evans,David | Insider | Buy | 1,215,000 | GBX 8 | £97,200 | |
| 7/6/2016 | Evans,David | Insider | Buy | 900,000 | GBX 6 | £54,000 | |
| 1/21/2016 | Evans,David | Insider | Buy | 1,000,000 | GBX 8 | £80,000 | |
| 12/2/2015 | Gillies,Malcolm | Insider | Buy | 438,714 | GBX 9 | £39,484.26 | |
| 3/10/2015 | David Evans | Insider | Buy | 250,000 | GBX 8.65 | £21,625 | |
(Data available from 1/1/2013 forward)
Headline Trends for Collagen Solutions PLC (LON:COS)
Latest Headlines for Collagen Solutions PLC (LON:COS)
| Source: |
|
Collagen Solutions PLC (COS) Chart for Friday, August, 18, 2017
